Our Science – Kreisl Website
Teri N. Kreisl, M.D.
Selected Publications |
 |
| 1)
Kreisl TN, Smith P, Sul J, Salgado C, Iwamoto FM, Shih JH, Fine HA. Continuous daily sunitinib for recurrent glioblastoma. J. Neurooncol. 111: 41-8, 2013. [Journal] |
|
| 2)
Kreisl TN, McNeill KA, Sul J, Iwamoto FM, Shih J, Fine HA. A phase I/II trial of vandetanib for patients with recurrent malignant glioma. Neuro-oncology. 14: 1519-26, 2012. [Journal] |
|
| 3)
Kreisl TN, Zhang W, Odia Y, Shih JH, Butman JA, Hammoud D, Iwamoto FM, Sul J, Fine HA. A phase II trial of single-agent bevacizumab in patients with recurrent anaplastic glioma. Neuro-oncology. 13: 1143-50, 2011. [Journal] |
|
| 4)
Fraum TJ, Kreisl TN, Sul J, Fine HA, Iwamoto FM. Ischemic stroke and intracranial hemorrhage in glioma patients on antiangiogenic therapy. J. Neurooncol. 105: 281-9, 2011. [Journal] |
|
| 5)
Lehky TJ, Iwamoto FM, Kreisl TN, Floeter MK, Fine HA. Neuromuscular junction toxicity with tandutinib induces a myasthenic-like syndrome. Neurology. 76: 236-41, 2011. [Journal] |
|
| 6)
Kreisl TN, Kotliarova S, Butman JA, Albert PS, Kim L, Musib L, Thornton D, Fine HA. A phase I/II trial of enzastaurin in patients with recurrent high-grade gliomas. Neuro-oncology. 12: 181-9, 2010. [Journal] |
|
| 7)
Moustakas A, Kreisl TN. New treatment options in the management of glioblastoma multiforme: a focus on bevacizumab. Onco Targets Ther. 3: 27-38, 2010. [Journal] |
|
| 8)
Iwamoto FM, Kreisl TN, Kim L, Duic JP, Butman JA, Albert PS, Fine HA. Phase 2 trial of talampanel, a glutamate receptor inhibitor, for adults with recurrent malignant gliomas. Cancer. 116: 1776-82, 2010. [Journal] |
|
| 9)
Park JK, Hodges T, Arko L, Shen M, Dello Iacono D, McNabb A, Olsen Bailey N, Kreisl TN, Iwamoto FM, Sul J, Auh S, Park GE, Fine HA, Black PM. Scale to predict survival after surgery for recurrent glioblastoma multiforme. J. Clin. Oncol. 28: 3838-43, 2010. [Journal] |
|
| 10)
Kreisl TN, Kim L, Moore K, Duic P, Kotliarova S, Walling J, Musib L, Thornton D, Albert PS, Fine HA. A phase I trial of enzastaurin in patients with recurrent gliomas. Clin. Cancer Res. 15: 3617-23, 2009. [Journal] |
|
| 11)
Kreisl TN, Lassman AB, Mischel PS, Rosen N, Scher HI, Teruya-Feldstein J, Shaffer D, Lis E, Abrey LE. A pilot study of everolimus and gefitinib in the treatment of recurrent glioblastoma (GBM). J. Neurooncol. 92: 99-105, 2009. [Journal] |
|
| 12)
Kreisl TN. Chemotherapy for malignant gliomas. Semin Radiat Oncol. 19: 150-4, 2009. [Journal] |
|
| 13)
Kreisl TN, Kim L, Moore K, Duic P, Royce C, Stroud I, Garren N, Mackey M, Butman JA, Camphausen K, Park J, Albert PS, Fine HA. Phase II trial of single-agent bevacizumab followed by bevacizumab plus irinotecan at tumor progression in recurrent glioblastoma. J. Clin. Oncol. 27: 740-5, 2009. [Journal] |
|
| 14)
Kreisl TN, Toothaker T, Karimi S, DeAngelis LM. Ischemic stroke in patients with primary brain tumors. Neurology. 70: 2314-20, 2008. [Journal] |
|
| 15)
Kreisl TN. Neurologic complications of antitumor antibody therapies. Curr Neurol Neurosci Rep. 8: 259-63, 2008. [Journal] |
|
| 16)
Kreisl TN, Panageas KS, Elkin EB, Deangelis LM, Abrey LE. Treatment patterns and prognosis in patients with human immunodeficiency virus and primary central system lymphoma. Leuk. Lymphoma. 49: 1710-6, 2008. [Journal] |
|
| 17)
Nguyen TD, DeAngelis LM. Brain metastases. Neurol Clin. 25: 1173-92, x-xi, 2007. [Journal] |
|
| 18)
Nguyen TD, Abrey LE. Brain metastases: old problem, new strategies. Hematol. Oncol. Clin. North Am. 21: 369-88, 2007. [Journal] |
|
| 19)
Nguyen TD, Abrey LE. Intracranial hemorrhage in patients treated with bevacizumab and low-molecular weight heparin. Clin Adv Hematol Oncol. 5: 375-6; discussion 377-9, 2007. [Journal] |
|
| 20)
Nguyen T, DeAngelis LM. Stroke in cancer patients. Curr Neurol Neurosci Rep. 6: 187-92, 2006. [Journal] |
|
| 21)
Nguyen T, Deangelis LM. Treatment of brain metastases. J Support Oncol. 2: 405-10; discussion 411-6, 2004. [Journal] |
|
| 22)
Lorenzl S, Albers DS, Relkin N, Ngyuen T, Hilgenberg SL, Chirichigno J, Cudkowicz ME, Beal MF. Increased plasma levels of matrix metalloproteinase-9 in patients with Alzheimer's disease. Neurochem. Int. 43: 191-6, 2003. [Journal] |
|
| 23)
Selesnick SH, Nguyen TD, Gutin PH, Lavyne MH. Posterior petrous face meningiomas. Otolaryngol Head Neck Surg. 124: 408-13, 2001. [Journal] |
|
| Click Here to View Collapsed Bibliography. |
This page was last updated on 4/16/2013.
